Fundació Assistencial Mutua de Terrassa
- Address
- Fundacio Assistencial Mutua de Terrassa, Edifici Estació (cex) Placa dels Drets Humans 1 Planta-3 Cons.308, 08222 Terrassa, Spain
Fundació Assistencial Mutua de Terrassa - Autonomic Disorders Research
Fundació Assistencial Mutua de Terrassa is a clinical research center with specialized expertise in autonomic nervous system disorders and neurodegenerative conditions. The center participates in advanced clinical trials investigating novel therapeutic approaches for complex neurological syndromes affecting the autonomic regulation of cardiovascular function.
- Neurogenic Orthostatic Hypotension (nOH) in neurodegenerative diseases
- Multiple System Atrophy (MSA) and related autonomic dysfunction
- Phase 3 clinical trials evaluating emerging pharmacological treatments
The center's research portfolio demonstrates particular strength in evaluating long-term efficacy and durability of treatments for symptomatic neurogenic orthostatic hypotension, utilizing sophisticated assessment tools including composite scoring systems to comprehensively measure patient outcomes in challenging neurodegenerative conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Fundació Assistencial Mutua de Terrassa
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Durability of Ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Phase 3 Study | Theravance Biopharma Ireland Limited | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ampreloxetine | 1 | Unknown | 2023-10-25 | 2023-10-25 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.